
| Duration | Percentage |
|---|---|
| 1 week | 0.78 |
| 1 month | -1.59 |
| 6 months | 49.35 |
| 9 months | 97.06 |
| 1 year | 88.41 |
| Essentials | |
|---|---|
| Fund category | Equity - Sector Fund |
| Scheme plan | Growth |
| Scheme type | Open Ended |
| Launch date | July 14, 1999 |
| Fund manager | Mr. Vivek Pandey |
| Fund info | |
|---|---|
| AMC | SBI Funds Management Pvt. Ltd. |
| Objective | The scheme aims to provide the investors maximum growth opportunity through equity investment in stocks of Pharma Sector. |
| Asset (Rs crore) | 32.10 ( August 31, 2009) |
| Dividend (%) | 39.00 ( December 31, 2004) |
| Company | Percentage |
|---|---|
| Lupin Ltd. | 11.21 |
| Cipla | 10.78 |
| GlaxoSmithKline Phar | 8.93 |
| Biocon | 8.9 |
| Aventis Pharma Ltd. | 8.76 |
| Opto Circuits India | 8.11 |
| Piramal Healthcare L | 7.72 |
| Wyeth Ltd. | 6.1 |
| Dishman Pharmaceutic | 5.92 |
| Glenmark Pharma | 5.92 |
| Company | Percentage |
|---|---|
| Pharmaceuticals | 81.0 |
| Medical Accessories | 8.0 |
| Miscellaneous | 4.0 |
| Packaging - Others | 3.0 |